Nikola Vučević
C· 6'9"· 265· Age 35
Nikola Vučević
#9· BOS· C· 6'9"· Age 35
2025-26
Proj.
GP
64
64.8
PPG
15.1
15.0
RPG
8.4
8.4
APG
3.3
3.3
FG%
49.3
0.5
3P%
36.9
0.4
FT%
82.8
0.8
eFG%
55.6
55.6
Nikola Vučević
C | 6'9" | 265 lbs | Age 35
2012 R1 Pick 16 | Southern California | Montenegro
$21.5M | 1 yr | UFA 2026
Projections
Career Outlook
HOF
52%
MVP
<1%
All-NBA
<1%
2025-26
Current
Proj.
GP
64
64.8
PPG
15.1
15.0
RPG
8.4
8.4
APG
3.3
3.3
Current
Proj.
FG%
49.3
49.3
3P%
36.9
36.9
FT%
82.8
82.8
eFG%
55.6
55.6
True Talent
Nikola Vučević
Career Statistics
Latest Projections
| Playing Time | Box Score | Volume | Shooting % | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2029-30 35% ret. | — | 39 | 55.3 | — | 20.5 | 9.4 | 5.5 | 1.9 | 0.5 | 0.5 | 1.0 | 3.8 | 7.9 | 1.2 | 3.1 | 0.7 | 0.9 | 47.4% | 37.0% | 78.6% |
| 2028-29 17% ret. | — | 38 | 56.5 | — | 22.2 | 10.5 | 6.1 | 2.1 | 0.5 | 0.5 | 1.1 | 4.2 | 8.9 | 1.3 | 3.4 | 0.8 | 1.1 | 47.5% | 36.9% | 79.4% |
| 2027-28 6% ret. | — | 37 | 60.0 | — | 23.9 | 11.7 | 6.8 | 2.4 | 0.6 | 0.5 | 1.2 | 4.7 | 9.8 | 1.3 | 3.6 | 0.9 | 1.2 | 48.4% | 37.1% | 80.6% |
| 2026-27 1% ret. | — | 36 | 65.5 | — | 26.5 | 13.5 | 7.8 | 2.8 | 0.6 | 0.6 | 1.3 | 5.5 | 11.2 | 1.5 | 3.9 | 1.1 | 1.3 | 48.9% | 37.3% | 80.8% |
| 2025-26 | BOS | 35 | 64.8 | — | 28.4 | 15.1 | 8.4 | 3.3 | 0.6 | 0.6 | 1.3 | 6.1 | 12.5 | 1.6 | 4.2 | 1.2 | 1.5 | 49.3% | 36.9% | 82.8% |
| 2025-26 | BOS | 35 | 64 | 49 | 28.4 | 15.1 | 8.4 | 3.3 | 0.6 | 0.6 | 1.3 | 6.2 | 12.5 | 1.6 | 4.2 | 1.2 | 1.5 | 49.3% | 36.9% | 82.8% |
| 2024-25 | CHI | 34 | 73 | 72 | 31.2 | 18.5 | 10.1 | 3.5 | 0.8 | 0.7 | 1.6 | 7.5 | 14.2 | 1.8 | 4.4 | 1.6 | 2.0 | 53.0% | 40.2% | 80.5% |
| 2023-24 | CHI | 33 | 76 | 74 | 34.3 | 18.0 | 10.5 | 3.3 | 0.7 | 0.8 | 1.6 | 7.7 | 15.9 | 1.2 | 4.1 | 1.4 | 1.7 | 48.4% | 29.4% | 82.2% |
| 2022-23 | CHI | 32 | 82 | 82 | 33.5 | 17.6 | 11.0 | 3.2 | 0.7 | 0.7 | 1.7 | 7.3 | 14.0 | 1.5 | 4.2 | 1.6 | 1.9 | 52.0% | 34.9% | 83.5% |
| 2021-22 | CHI | 31 | 73 | 73 | 33.1 | 17.6 | 11.0 | 3.2 | 1.0 | 1.0 | 1.9 | 7.5 | 15.8 | 1.4 | 4.5 | 1.3 | 1.7 | 47.3% | 31.4% | 76.0% |
| 2020-21 | CHI | 30 | 70 | 70 | 33.5 | 23.4 | 11.7 | 3.8 | 0.9 | 0.7 | 1.8 | 9.5 | 19.9 | 2.5 | 6.3 | 1.9 | 2.2 | 47.7% | 40.0% | 84.0% |
| 2019-20 | ORL | 29 | 62 | 62 | 32.2 | 19.6 | 10.9 | 3.6 | 0.9 | 0.8 | 1.4 | 8.0 | 16.7 | 1.6 | 4.7 | 2.1 | 2.7 | 47.7% | 33.9% | 78.4% |
| 2018-19 | ORL | 28 | 80 | 80 | 31.4 | 20.8 | 12.0 | 3.8 | 1.0 | 1.1 | 2.0 | 8.8 | 16.9 | 1.1 | 2.9 | 2.2 | 2.8 | 51.8% | 36.4% | 78.9% |
| 2017-18 | ORL | 27 | 57 | 57 | 29.5 | 16.5 | 9.2 | 3.4 | 1.0 | 1.1 | 1.9 | 7.0 | 14.7 | 1.1 | 3.6 | 1.4 | 1.6 | 47.5% | 31.4% | 81.9% |
| 2016-17 | ORL | 26 | 75 | 55 | 28.8 | 14.6 | 10.4 | 2.8 | 1.0 | 1.0 | 1.6 | 6.4 | 13.7 | 0.3 | 1.0 | 1.4 | 2.1 | 46.8% | 30.7% | 66.9% |
| 2015-16 | ORL | 25 | 65 | 60 | 31.3 | 18.2 | 8.9 | 2.8 | 0.8 | 1.1 | 1.9 | 8.2 | 16.1 | 0.0 | 0.1 | 1.7 | 2.3 | 51.0% | 22.2% | 75.3% |
| 2014-15 | ORL | 24 | 74 | 74 | 34.2 | 19.3 | 10.9 | 2.0 | 0.7 | 0.7 | 2.0 | 8.5 | 16.3 | 0.0 | 0.1 | 2.2 | 2.9 | 52.3% | 33.3% | 75.2% |
| 2013-14 | ORL | 23 | 57 | 57 | 31.8 | 14.2 | 11.0 | 1.8 | 1.1 | 0.8 | 2.0 | 6.2 | 12.2 | 0.0 | 0.0 | 1.8 | 2.4 | 50.7% | - | 76.6% |
| 2012-13 | ORL | 22 | 77 | 77 | 33.2 | 13.1 | 11.9 | 1.9 | 0.8 | 1.0 | 1.8 | 6.0 | 11.5 | 0.0 | 0.0 | 1.1 | 1.6 | 51.9% | 0.0% | 68.3% |
| 2011-12 | PHI | 21 | 51 | 15 | 15.9 | 5.5 | 4.8 | 0.6 | 0.4 | 0.7 | 0.6 | 2.6 | 5.7 | 0.1 | 0.2 | 0.4 | 0.7 | 45.0% | 37.5% | 52.9% |